| scholarly article | Q13442814 |
| P2093 | author name string | J. S. Silva | |
| F. Q. Cunha | |||
| G. N. Vespa | |||
| P2860 | cites work | Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major | Q72285880 |
| Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis | Q72842759 | ||
| Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones | Q29622840 | ||
| Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha | Q34159500 | ||
| Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages | Q34240927 | ||
| Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst | Q34344898 | ||
| Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates | Q35780641 | ||
| Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages | Q35811316 | ||
| Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). | Q36230329 | ||
| Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection | Q36230811 | ||
| Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity | Q36341618 | ||
| Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma | Q36354239 | ||
| Nitrate biosynthesis in man | Q36384530 | ||
| Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates | Q36968357 | ||
| Chagas' disease and blood transfusion | Q39848707 | ||
| Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. | Q41282648 | ||
| The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta | Q41600919 | ||
| Identification of N-iminoethyl-l-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells | Q41706646 | ||
| Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi | Q41836442 | ||
| Enzymatic formation of nitrogen oxides from L-arginine in bovine brain cytosol | Q42191863 | ||
| Synergistic protection by specific antibodies and interferon against infection byTrypanosoma cruzi in vitro | Q42817754 | ||
| Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine | Q43518726 | ||
| Macrophage cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism. | Q43876088 | ||
| IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages | Q44173170 | ||
| Resistance toLeishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages | Q54284360 | ||
| Release of nitric oxide during the experimental infection with Trypanosoma cruzi | Q58843986 | ||
| Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection | Q58844496 | ||
| In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections | Q58845682 | ||
| Reticulo-endothelial blockade in experimental Chagas' disease | Q58850567 | ||
| Connective Tissue Reactions in Normal and Immunized Mice to a Reticulotropic Strain of Trypanosoma Cruzi | Q58851411 | ||
| Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism | Q67267340 | ||
| IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha | Q67724002 | ||
| Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma | Q68343965 | ||
| Failure of Trypanosoma cruzi to trigger the respiratory burst of activated macrophages. Mechanism for immune evasion and importance of oxygen-independent killing | Q68451630 | ||
| Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine | Q68739930 | ||
| Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine | Q68857714 | ||
| Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production | Q70405593 | ||
| Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages | Q70411572 | ||
| Reactive nitrogen intermediates suppress the primary immunologic response to Listeria | Q72073828 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 5177-5182 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro | |
| P478 | volume | 62 |
| Q37241027 | A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase |
| Q41951713 | Activity of cholinesterases and adenosine deaminase in blood and serum of rats experimentally infected with Trypanosoma cruzi |
| Q33881623 | Acute Chagas disease induces cerebral microvasculopathy in mice |
| Q37215305 | Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection |
| Q40919170 | Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages |
| Q26866224 | Bioactive lipids in Trypanosoma cruzi infection |
| Q58845623 | CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi |
| Q39510568 | CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation |
| Q33768862 | CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates |
| Q52718692 | Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis. |
| Q42983153 | Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections |
| Q28391025 | Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease |
| Q40840535 | Cytokines and nitric oxide as effector molecules against parasitic infections |
| Q34006725 | DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide |
| Q39570411 | Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase |
| Q35140428 | Deficiency in mannose-binding lectin-associated serine protease-2 does not increase susceptibility to Trypanosoma cruzi infection |
| Q58842383 | Diet Modulates Adipose Tissue Oxidative Stress in a Murine Acute Chagas Model |
| Q39863865 | Differential interleukin-8 and nitric oxide production in epithelial cells induced by mucosally invasive and noninvasive Trypanosoma cruzi trypomastigotes |
| Q58846761 | Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy |
| Q60047543 | Disease Tolerance and Pathogen Resistance Genes May Underlie Persistence and Differential Progression to Chagas Disease Cardiomyopathy |
| Q37271763 | During acute experimental infection with the reticulotropic Trypanosoma cruzi strain Tulahuen IL-22 is induced IL-23-dependently but is dispensable for protection |
| Q42369872 | Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation |
| Q48230391 | Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites |
| Q33754761 | Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes. |
| Q33358639 | Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease |
| Q35425660 | Enhancement of macrophage microbicidal activity: supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi |
| Q38132635 | Epidemiology of Chagas disease in Europe: many calculations, little knowledge |
| Q38927945 | Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation |
| Q37392826 | Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors |
| Q44684976 | Experimental chemotherapy in paracoccidioidomycosis using ruthenium NO donor |
| Q53683164 | Extracellular Vesicles Shed By Trypanosoma cruzi Potentiate Infection and Elicit Lipid Body Formation and PGE2 Production in Murine Macrophages. |
| Q52931841 | Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. |
| Q34001357 | Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control |
| Q26774821 | Gastrointestinal Parasites and the Neural Control of Gut Functions |
| Q33847317 | Genetic and functional role of TNF-alpha in the development Trypanosoma cruzi infection. |
| Q50264189 | Glycoconjugates prevent B. anthracis toxin-induced cell death through binding while activating macrophages |
| Q40410786 | Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents |
| Q57034192 | Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection |
| Q33532584 | IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis |
| Q30452989 | Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection |
| Q24602785 | Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice |
| Q33818765 | Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice |
| Q41849739 | In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure |
| Q35995235 | In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors |
| Q36655156 | Increased cytokine and nitric oxide levels in serum of dogs experimentally infected with Rangelia vitalii |
| Q37190915 | Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease |
| Q36377044 | Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii |
| Q34756581 | Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice |
| Q58849763 | Induction of proinflammatory cytokines and nitric oxide by Trypanosoma cruzi in renal cells |
| Q35999538 | Inflammation Enhances the Risks of Stroke and Death in Chronic Chagas Disease Patients |
| Q35103439 | Interferon-gamma promotes infection of astrocytes by Trypanosoma cruzi |
| Q38730116 | Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice |
| Q39559044 | Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi |
| Q35494931 | Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes |
| Q36080155 | Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues. |
| Q33867259 | Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice |
| Q35512116 | Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium. |
| Q34128916 | Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection |
| Q33587079 | Metallothionein-1 and nitric oxide expression are inversely correlated in a murine model of Chagas disease |
| Q37328752 | MnSODtg mice control myocardial inflammatory and oxidative stress and remodeling responses elicited in chronic Chagas disease |
| Q33700821 | Moderate Treadmill Exercise Training Improves Cardiovascular and Nitrergic Response and Resistance to Trypanosoma cruzi Infection in Mice |
| Q35842054 | Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection |
| Q64916705 | Myocarditis in Humans and in Experimental Animal Models. |
| Q34163899 | NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection. |
| Q55241672 | NLRP3 Inflammasome and Caspase-1/11 Pathway Orchestrate Different Outcomes in the Host Protection Against Trypanosoma cruzi Acute Infection. |
| Q35010454 | NLRP3 controls Trypanosoma cruzi infection through a caspase-1-dependent IL-1R-independent NO production |
| Q44518346 | Neutralization of B. anthracis toxins during ex vivo phagocytosis |
| Q42152162 | Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes |
| Q34299137 | Nitro/nitrosyl-ruthenium complexes are potent and selective anti-Trypanosoma cruzi agents causing autophagy and necrotic parasite death |
| Q40291208 | Pathogenesis of Chagas disease: time to move on. |
| Q35750253 | Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection |
| Q34001078 | Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. |
| Q46802809 | Polymeric glycoconjugates protect and activate macrophages to promote killing of Bacillus cereus spores during phagocytosis |
| Q58843806 | Programmed death ligand 2 regulates arginase induction and modifies Trypanosoma cruzi survival in macrophages during murine experimental infection |
| Q35462159 | Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells |
| Q44360313 | Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response |
| Q36670368 | Role of nitric oxide in parasitic infections |
| Q39419338 | Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection |
| Q34139961 | Sympathetic glial cells and macrophages develop different responses to Trypanosoma cruzi infection or lipopolysaccharide stimulation. |
| Q37287238 | The Aryl Hydrocarbon Receptor Modulates Production of Cytokines and Reactive Oxygen Species and Development of Myocarditis during Trypanosoma cruzi Infection. |
| Q34301086 | The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi |
| Q35838023 | The Immune Response to Trypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine Development |
| Q97521468 | The Recombinant Form of Trypanosoma cruzi P21 Controls Infection by Modulating Host Immune Response |
| Q28246832 | The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice |
| Q34301095 | The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi |
| Q33764616 | The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide |
| Q45118919 | The gills are an important site of iNOS expression in rainbow trout Oncorhynchus mykiss after challenge with the gram-positive pathogen Renibacterium salmoninarum |
| Q71834571 | The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils |
| Q38006608 | The potential of nitric oxide releasing therapies as antimicrobial agents |
| Q24288682 | The quality of methods reporting in parasitology experiments |
| Q45927196 | The trypanocidal effect of NO-releasing agents is not due to inhibition of the major cysteine proteinase in Trypanosoma brucei. |
| Q64972901 | Trypanosoma cruzi Infection Induces Cellular Stress Response and Senescence-Like Phenotype in Murine Fibroblasts. |
| Q26823791 | Trypanosoma cruzi infection and host lipid metabolism |
| Q34096517 | Trypanosoma cruzi infection in genetically selected mouse lines: genetic linkage with quantitative trait locus controlling antibody response. |
| Q39571751 | Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice |
| Q36974519 | Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine |
| Q35457307 | Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages |
| Q42957081 | Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. |
| Q38105519 | Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections |
| Q47557112 | Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease |
| Q34001865 | beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi |
Search more.